Standout Papers
Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
2010 Standout
Primary Prevention of Cardiovascular Mortality and Events With Statin Treatments
2008
Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170 255 patients from 76 randomized trials
2010
Adherence with statins in a real-life setting is better when associated cardiovascular risk factors increase: a cohort study
2011
Cardiac Care for Older Adults
2011
The safety of statins in clinical practice
2007
Defining consensus: A systematic review recommends methodologic criteria for reporting of Delphi studies
2014 Standout
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
2010 Standout
Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention
2009
Meta-Analysis of the Relationship Between Non–High-Density Lipoprotein Cholesterol Reduction and Coronary Heart Disease Risk
2009
Drug Treatment of Hyperlipidemia in Women
2004
Vascular dementia
2015 Standout
Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial
2003
The Cost Effectiveness of Statin Therapies in Spain in 2010, after the Introduction of Generics and Reference Prices
2010
Low density lipoprotein cholesterol, statins and cardiovascular events: a meta–analysis
2006
Long‐term Cardiac Outcomes in Renal Transplant Recipients Receiving Fluvastatin: The ALERT Extension Study
2005
What is self-rated health and why does it predict mortality? Towards a unified conceptual model
2009 Standout
The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease
2004 Standout
The metabolic syndrome
2010 Standout
Statins for Primary Prevention of Cardiovascular Mortality in Women: A Systematic Review and Meta-Analysis
2009
A randomised controlled trial of four weeks versus seven weeks of pulmonary rehabilitation in chronic obstructive pulmonary disease
2001
A prospective study of 1000 hernias: results of the Plymouth Hernia Service
2003
Interpretation of Changes in Health-related Quality of Life
2003 Standout
An Introduction to the Five‐Factor Model and Its Applications
1992 Standout
Effect of the Magnitude of Lipid Lowering on Risk of Elevated Liver Enzymes, Rhabdomyolysis, and Cancer
2007
Age and gender bias in statin trials
2001
The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment
2005 Standout
Impact of gender in primary prevention of coronary heart disease with statin therapy: A meta-analysis
2008
Intensive Statin Therapy and the Risk of Hospitalization for Heart Failure After an Acute Coronary Syndrome in the PROVE IT–TIMI 22 Study
2006
Effects of a Dietary Portfolio of Cholesterol-Lowering Foods vs Lovastatin on Serum Lipids and C-Reactive Protein
2003
A Prospective Natural-History Study of Coronary Atherosclerosis
2011 Standout
Niacin and fibrates in atherogenic dyslipidemia: Pharmacotherapy to reduce cardiovascular risk
2010
Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial
2006
Baseline Characteristics of Participants in the JUPITER Trial, A Randomized Placebo-Controlled Primary Prevention Trial of Statin Therapy Among Individuals With Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein
2007
The Clinical and Economic Burden of Nonadherence with Antihypertensive and Lipid-Lowering Therapy in Hypertensive Patients
2008
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
2010 Standout
Cardiovascular and Cancer Mortality in Very Elderly Post-Myocardial Infarction Patients Receiving Statin Treatment
2010
Hernias: inguinal and incisional
2003 Standout
Relation of Different Measures of Low-Density Lipoprotein Cholesterol to Risk of Coronary Artery Disease and Death in a Meta-Regression Analysis of Large-Scale Trials of Statin Therapy
2010
Intensive Lowering of Low-Density Lipoprotein Cholesterol Levels for Primary Prevention of Coronary Artery Disease
2009
Effectiveness of Statin Therapy in Adults With Coronary Heart Disease
2004
Health status measurement in chronic obstructive pulmonary disease
2001
Lack of Effect of Lowering LDL Cholesterol on Cancer: Meta-Analysis of Individual Data from 175,000 People in 27 Randomised Trials of Statin Therapy
2012
Self-esteem and persistence in the face of failure.
2002
Meta-Analysis of Cardiovascular Outcomes Trials Comparing Intensive Versus Moderate Statin Therapy
2006
Statin Use and Incident Frailty in Women Aged 65 Years or Older: Prospective Findings From the Women's Health Initiative Observational Study
2008
Impact of Systemic Hypertension on the Cardiovascular Benefits of Statin Therapy—A Meta-Analysis
2008
Creatine supplementation during pulmonary rehabilitation in chronic obstructive pulmonary disease
2005
Statin Safety: A Systematic Review
2006
Coherence and congruence: Two aspects of personality integration.
1995
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
Outcomes of Using High- or Low-Dose Atorvastatin in Patients 65 Years of Age or Older with Stable Coronary Heart Disease
2007
Primary Prevention of Cardiovascular Disease with Statins in the Elderly
2014
Cardiovascular Event Reduction and Adverse Events Among Subjects Attaining Low-Density Lipoprotein Cholesterol <50 mg/dl With Rosuvastatin
2011
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
2003 Standout
The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials
2009
Prevention of Cardiovascular Disease in Persons with Type 2 Diabetes Mellitus: Current Knowledge and Rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
2007
Self-determination theory and the facilitation of intrinsic motivation, social development, and well-being.
2000 Standout
Alzheimer's Disease
2010 Standout
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
2020 StandoutNobel
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
New and emerging data from clinical trials of statins
2004
Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial
2000
Constructive and unconstructive repetitive thought.
2008 Standout
Statins and All-Cause Mortality in High-Risk Primary Prevention
2010
Safety of Aggressive Lipid Management
2007
Statin-Associated Myopathy
2003
Dispositional pessimism predicts delayed return to normal activities after inguinal hernia operation
2003
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Pleiotropic Effects of Statins
2010
Pravastatin and cognitive function in the elderly. Results of the PROSPER study
2009
Effects of statins on stroke prevention in patients with and without coronary heart disease: A meta-analysis of randomized controlled trials
2004
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
2007 Standout
Prevention of Coronary and Stroke Events with Atorvastatin in Hypertensive Patients who have Average or Lower-than-Average Cholesterol Concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial???Lipid Lowering Arm (ASCOT-LLA)
2004
Benefits of Statins in Elderly Subjects Without Established Cardiovascular Disease
2013
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
2004 Standout
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
2008 Standout
Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy
2010
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
2004 Standout
Alzheimer's disease: the cholesterol connection
2003
The Dynamics of Learning and Allocation of Study Time to a Region of Proximal Learning.
2003
Mevalonate pathway: A review of clinical and therapeutical implications
2007
Pathways towards and away from Alzheimer's disease
2004 StandoutNature
Statins and the Risk of Colorectal Cancer
2005
Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S)
2004
Statins: An essential component in the management of carotid artery disease
2007
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease
2005 Standout
Pulmonary Rehabilitation
2007
Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004—BHS IV
2004
Comparison of Discriminative Properties among Disease-specific Questionnaires for Measuring Health-related Quality of Life in Patients with Chronic Obstructive Pulmonary Disease
1998
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Analysis of the Factors Related to Mortality in Chronic Obstructive Pulmonary Disease
2003
Coronary heart disease prevention and age inequalities: the first year of the National Service Framework for CHD.
2005
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Dissecting racial bias in an algorithm used to manage the health of populations
2019 StandoutScience
Self-determination theory and the facilitation of intrinsic motivation, social development, and well-being.
2000 Standout
The "What" and "Why" of Goal Pursuits: Human Needs and the Self-Determination of Behavior
2000 Standout
Statin Therapy and the Risk of Intracerebral Hemorrhage
2012
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
2006 Standout
Pravastatin and the Development of Diabetes Mellitus
2001
Usefulness of Pravastatin in Primary Prevention of Cardiovascular Events in Women
2008
Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack
2008
Origins and functions of positive and negative affect: A control-process view.
1990 Standout
Benefits of Pravastatin on Cardiovascular Events and Mortality in Older Patients with Coronary Heart Disease Are Equal to or Exceed Those Seen in Younger Patients: Results from the LIPID Trial
2001
Angiotensin‐Converting Enzyme Inhibitor and Statin Use and Incident Mobility Limitation in Community‐Dwelling Older Adults: The Health, Aging and Body Composition Study
2011
The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): Design and baseline characteristics
2008
The effects of feedback interventions on performance: A historical review, a meta-analysis, and a preliminary feedback intervention theory.
1996 Standout
Expectancy, valence, and motivational force functions in goal-setting research: An empirical test.
1993
Statins for the primary prevention of cardiovascular disease
2013
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
2018 Standout
Statins in Stroke Prevention and Carotid Atherosclerosis
2004
Moving from Cognition to Action: A Control Theory Perspective
1994
An Application of Control Theory to Understanding the Relationship Between Performance and Satisfaction
1991
Goal constructs in psychology: Structure, process, and content.
1996 Standout
Rosuvastatin for Primary Prevention in Older Persons With Elevated C-Reactive Protein and Low to Average Low-Density Lipoprotein Cholesterol Levels: Exploratory Analysis of a Randomized Trial
2010
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
2004
Esteem Threat, Self-Regulatory Breakdown, and Emotional Distress as Factors in Self-Defeating Behavior
1997
The Critical Importance of Retrieval for Learning
2008 StandoutScience
Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions
2016
A systematic review and economic evaluation of statins for the prevention of coronary events
2007
Mild cognitive impairment
2005
Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions
2004
Effects of Intensive Glucose Lowering in Type 2 Diabetes
2008 Standout
Self-esteem and persistence in the face of failure.
2002
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial
2003
Pursuing Personal Goals: Skills Enable Progress, but Not all Progress is Beneficial
1998
Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis
2008
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
2012 Standout
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
2004 Standout
Abstract versus concrete goals: Personal striving level, physical illness, and psychological well-being.
1992
Is it Time for a Cardiovascular Primary Prevention Trial in the Elderly?
2006
Toward a general model of self-regulated study: An analysis of selection of items for study and self-paced study time.
1999
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
2005 Standout
The Joint Effects of Target and Purpose Goals on Intrinsic Motivation: A Mediational Analysis
1998
Works of Michael E. Hyland being referenced
Delphi-Derived Development of a Common Core for Measuring Complementary and Alternative Medicine Prevalence
2009
A Prospective Study of Pravastatin in the Elderly at Risk (PROSPER): Screening Experience and Baseline Characteristics
2002
The design of a prospective study of pravastatin in the elderly at risk (PROSPER)
1999
Domains, constructs and the development of the breathing problems questionnaire
1994
A comparison of three disease-specific and two generic health-status measures to evaluate the outcome of pulmonary rehabilitation in COPD
2001
A short outpatient pulmonary rehabilitation programme: immediate and longer term effects on exercise performance and quality of life
1998
The validity of health assessments: Resolving some recent differences
1993
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
2002 Standout
Development of a shortened version of the Breathing Problems Questionnaire suitable for use in a pulmonary rehabilitation clinic: a purpose-specific, disease-specific questionnaire.
1998
Derivation and Validation of a Composite Index of Severity in Chronic Obstructive Pulmonary Disease
2009
Lichtenstein patch or Perfix plug-and-patch in inguinal hernia: A prospective double-blind randomized controlled trial of short-term outcome
2000
There Is No Motive to Avoid Success: The Compromise Explanation for Success‐Avoiding Behavior
1989
Prospective double-blind randomized study comparing Perfix� plug-and-patch with Lichtenstein patch in inguinal hernia repair: one year quality of life results
2000
Control theory interpretation of psychological mechanisms of depression: Comparison and integration of several theories.
1987
Control theory interpretation of psychological mechanisms of depression: Comparison and integration of several theories.
1987
Do person variables exist in different ways?
1985
Motivational control theory: An integrative framework.
1988
Plasma Lipoproteins and Apolipoproteins as Predictors of Cardiovascular Risk and Treatment Benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)
2005
The Effect of Rehabilitation on Positive Interpretations of Illness
2002
Motivational control theory: An integrative framework.
1988